Pancreatic Adenocarcinoma Gene Environment Risk Study (PAGER)

University of Pittsburgh

Status

Enrolling

Conditions

Pancreatic Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT00912717

STUDY19070256

Details and patient eligibility

About

After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.

Enrollment

10,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Histologically confirmed or CT confirmed diagnosis of pancreatic adenocarcinoma
Subjects with abnormal imaging study (CT, MRI, MRCP, EUS)
Control subjects with a clinical diagnosis of a pancreas, liver, or intestinal condition
Control subject with acute pancreatitis
Control subject with chronic pancreatitis
Control subject with biliary obstruction
Control subject with pancreatic cyst
Member of a high risk family (≥ 1 close relative with pancreatic cancer)
Healthy control (without any of the above conditions)